Scotts Miracle Gro (NYSE:SMG) Stock, Quote.Headers.trade-ideas

Scotts Miracle Gro

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the us. The business consists of three reporting segments: us consumer, Hawthorne, and other. The us consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. us consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the us, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

The Scotts Miracle Gro

AI-Generated Image

Cannabis

News

Politics

Markets

ETFs

CANN

CRBP

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GRWG

GTBIF

HITI

IIPR

MJNA

MSOS

PLNHF

SNDL

TCNNF

TLRY

YOLO

HEXO

Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.

Cannabis Stocks React To Trump&#39;s Marijuana Comments: See Which Ones Posted Solid Gains

Small Cap Analysis

Small Cap

Trading Ideas

Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump&#39;s comments on the legalization of marijuana in Florida.

Trump&#39;s Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Movers

Intraday Update

ANET

FVRR

MTCH

NVDA

POWL

SAVA

SDST

TEVA

Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA  And Other Big Stocks Moving Higher On Wednesday

Scotts Miracle-Gro Company (The) Common Stock

The Scotts Miracle Gro Co

San Miguel Corp

SIGMATA ELECTRONICS INC by SIGMATA ELECTRONICS INC.

Sigmata Electronics Inc

SMG INDUSTRIES INC by SMG Industries, Inc.

SMG Industries Inc

Smiths Group PLC

SAN MIGUEL BREWERY LTD by San Miguel Brewery Ltd.

San Miguel Brewery Hong Kong Ltd

SUMMERSET GROUP HLD ORD by Summerset Group Holdings Ltd, Wellington

Summerset Group Holdings Ltd

SMITHS GROUP PLC S/ADR by Smiths Group Plc

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 24.17% at $0.34</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 22.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 19.04% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 12.41% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.63% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 8.92% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 8.90% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 8.20% at $55.81</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 7.26% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 6.72% at $2.50</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 5.71% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.94% at $69.74</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.83% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 3.18% at $2.92</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 26.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed down 21.43% at $0.63</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 21.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 18.07% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 12.56% at $11.47</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 6.48% at $4.45</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 3.26% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 3.03% at $0.05</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMMJ

CBDY

CLSH

CNBX

CPHRF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

CWBHF

CXXIF

EAST

FFNTF

GBHPF

GNLN

OILFF

RMHB

RSSFF

SOLCF

TGIFF

XXII

Cannabis Stock Gainers And Losers From September 13, 2024

Former President Donald Trump announced on Sunday night that, if re-elected, he would reschedule cannabis and support banking reforms for the marijuana industry. He also confirmed his support for Florida's Amendment 3, which would legalize recreational cannabis in the state. Trump's <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">comments</a> sparked a reaction in the cannabis stock market on Monday.
Get Benzinga's exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">Stocks Reaction</h3>
<ul>
<li>Trulieve Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>): The price at market close was $10.99 with a change of +$1.28 (+13.18%). Trading volume reached 707,392, with a market cap of $2.06 billion.</li>
<li>Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>): The price at market close was $10.66 with a change of +$1.02 (+10.58%). Trading volume hit 473,092, with a market cap of $2.52 billion.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): The price at market close was $3.10 with a change of +$0.26 (+9.15%). Trading volume reached 639,920, and the market cap stood at $2.09 billion.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): The price at market close was $4.86 with a change of +$0.38 (+8.54%). Trading volume was 6,041,892, with a market cap of $412 million.</li>
<li>Sundial Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>): The price at market close was $2.14 with a change of +$0.16 (+8.08%). Trading volume hit 1,946,306, and the market cap was $530 million.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): The price at market close was $5.80 with a change of +$0.39 (+7.25%). Trading volume was 1,136,294, with a market cap of $317 million.</li>
<li>Cronos Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>): The price at market close was $2.21 with a change of +$0.07 (+3.27%). Trading volume reached 1,448,055, with a market cap of $847 million.</li>
<li>HEXO Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NASDAQ">HEXO</a>): The price at market close was $1.35 with a change of +$0.05 (+3.85%). Trading volume was 1,215,840, with a market cap of $401 million.</li>
<li>AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>): The price at market close was $7.16 with a change of +$0.75 (+11.70%). Trading volume hit 13,998,304.</li>
<li>Innovative Industrial Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>): The price at market close was $122.69 with a change of +$2.02 (+1.67%). Trading volume was 90,181, with a market cap of $3.42 billion.</li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>): The price at market close was $1.92 with a change of +$0.05 (+2.96%). Trading volume hit 454,306, and the market cap was $110 million.</li>
<li>Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>): The price at market close was $52.48 with a change of +$2.43 (+4.87%). Trading volume was 153,424, with a market cap of $630 million.</li>
<li>AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>): The price at market close was $3.35 with a change of +$0.21 (+6.69%). Trading volume reached 37,519.</li>
<li>Scotts Miracle-Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>): The price at market close was $67.62 with a change of -$0.20 (-0.29%). Trading volume reached 323,540, with a market cap of $3.85 billion.</li>
<li>Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>): The price at market close was $1.01 with a change of +$0.01 (+1.02%). Trading volume hit 459,136, and the market cap was $113 million.</li>
<li>Trees (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>): The price at market close was $0.042 with a change of -$0.012 (-22.22%). Trading volume was 118,407.</li>
<li>Medical Marijuana (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>): The price at market close was $0.001 with no change. Trading volume hit 9,393,761, with a market cap of $5.68 million.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>): The price at market close was $1.83 with a change of +$0.08 (+4.29%). Trading volume was 348,054, with a market cap of $186 million.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>): The price at market close was $2.12 with a change of +$0.16 (+8.16%). Trading volume hit 648,008, with a market cap of $162 million.</li>
<li>Planet 13 Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTC">PLNHF</a>): The price at market close was $0.96 with no significant change. Trading volume was 275,004.</li>
<li>Cresco Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>): The price at market close was $1.74 with a change of +$0.13 (+7.74%). Trading volume hit 438,517, with a market cap of $565 million.</li>
</ul>
<h3 class="wp-block-heading">Highs And Lows In 2024&nbsp;</h3>
The cannabis market has experienced several significant stock movements in recent months. On April 30, 2024, stocks soared after the DEA announced plans to reschedule cannabis to Schedule III, with Canopy Growth <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38536953/cannabis-stocks-react-to-dea-rescheduling-canopy-aurora-surge-tilray-wm-tech-hold-s">jumping</a> by 78.8% and Aurora Cannabis rising 46%. 
However, two weeks ago, following the DEA's decision to delay its final ruling, the sector saw a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40580306/cannabis-stocks-plummet-by-up-to-16-on-dea-rescheduling-delay-could-this-be-the-buy">sharp decline</a>, with Curaleaf falling 15.68% and Green Thumb Industries dropping 10.15%. In contrast, Monday's gains following Trump's support for Amendment 3 were more modest, with a mean growth of 4.31%, suggesting a recovery but not on the same scale as the April surge.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40776937/trump-joins-millions-of-americans-who-support-rescheduling-cannabis-weed-industry-responds-to-fo">Trump &#8216;Joins Millions Of Americans&#8217; Who Support Rescheduling Cannabis: Weed Industry Responds To Former Pres&#8217; News</a>

Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains

The cannabis market is abuzz following former President Donald Trump&#8217;s recent comments supporting cannabis legalization in Florida.&nbsp;
During a podcast interview, Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40697992/trump-talks-legal-weed-on-lex-fridman-podcast-we-can-live-with-the-marijuana">backed the state&#8217;s recreational cannabis initiative </a>and emphasized the need for a lawful and regulated framework.&nbsp;
This comes as Florida prepares to vote on a ballot initiative in November, which could reshape the cannabis landscape.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Top Performers And Decliners After Trump&#8217;s Comments On Marijuana </h3>
Stocks in the cannabis sector showed varied reactions on Wednesday, after <a href="https://www.benzinga.com/markets/cannabis/24/09/40677600/harris-campaign-slams-donald-trump-over-cannabis-shift-calls-it-brazen-flip-flop">Trump&#8217;s comments</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>) AdvisorShares Pure Cannabis ETF led the gainers, climbing 3.48% to $3.27, reflecting investor optimism around potential federal changes.&nbsp;
(OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) Trees Corporation experienced a plunge, down 99.8%, closing at $0.0001. Among the notable losers, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) Canopy Growth dropped 3.37% to $4.87, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) Cronos Group slipped 1.79% to $2.20.
Other stocks remained relatively stable. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) Tilray Brands fell 1.19%, ending at $1.67, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) Aurora Cannabis dipped 1.37% to $5.76.&nbsp;
Meanwhile, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) Sundial Growers climbed 2.53%, closing at $2.00, and (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) Trulieve Cannabis posted a 3.72% gain to $9.75, reflecting positive sentiment around these companies.
Read Also:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40712816/what-trump-learned-about-marijuana-that-desantis-did-not-and-why-the-gop-might-become-weed-frien">What Trump Learned About Marijuana That DeSantis Did Not And Why The GOP Might Become Weed-Friendly</a>
<h3 class="wp-block-heading">Stocks To Watch </h3>
<ul>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) AdvisorShares Pure US Cannabis ETF ended the day with a slight decline of 0.31%, closing at $6.48.</li>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) Innovative Industrial Properties, a key player in cannabis real estate, dropped 0.82%, closing at $121.58, showing a more cautious response from investors.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) Green Thumb Industries posted a modest gain of 0.67%, closing at $9.83, indicating optimism.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>) Medical Marijuana Inc. surged 10%, finishing at $0.0011, reflecting renewed interest despite its low price point.</li>
</ul>
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40713542/2024-election-cannabis-swing-state-voters-back-legalization-new-poll-reveals">2024 Election &amp; Cannabis: Swing State Voters Back Legalization, New Poll Reveals</a>

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 55.80% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 21.98% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 21.95% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 20.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 16.10% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 11.76% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 11.58% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 10.39% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 7.32% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 6.38% at $6.67</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 5.50% at $2.30</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.55% at $71.78</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed up 3.33% at $0.90</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 3.13% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OGI">OrganiGram Holdings</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.09% at $2.02</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 54.63% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 18.18% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 15.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.85% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 5.69% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 5.00% at $11.40</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 4.72% at $0.34</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.07% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed down 3.09% at $0.81</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBRRF

BLOZF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNPOF

ELLXF

FUAPF

GENE

KAYS

LMLLF

LVRLF

NWVCF

Cannabis Stock Gainers And Losers From August 23, 2024

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 25.00% at $0.001</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 15.83% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 11.11% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 10.55% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.59% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 8.93% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 8.33% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 8.03% at $0.33</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 7.29% at $2.06</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 6.25% at $0.73</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 5.58% at $54.91</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 4.90% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 4.71% at $0.36</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 4.00% at $1.36</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed up 3.36% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.04% at $72.59</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF">Australis Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed down 100.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 24.40% at $13.04</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 21.22% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 13.33% at $0.23</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 12.76% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 12.50% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 11.47% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 10.58% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 8.23% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 6.10% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 5.13% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.88% at $0.59</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 4.55% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 4.00% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 3.53% at $0.15</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUSAF

CARA

CNTMF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

MRMD

UGRO

Cannabis Stock Movers For August 15, 2024

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 40.00% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 33.04% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed up 27.03% at $1.64</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 15.93% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 13.60% at $7.05</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 12.47% at $10.28</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 12.33% at $1.62</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 11.80% at $53.60</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 10.10% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 8.76% at $6.92</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 7.17% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 6.62% at $11.76</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 6.50% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 6.41% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 6.29% at $1.85</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 5.92% at $3.38</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 5.71% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 5.06% at $9.88</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 4.96% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 4.87% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 4.74% at $1.98</li>
<li><a href="https://www.benzinga.com/quote/OGI">OrganiGram Holdings</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 4.02% at $1.54</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 3.96% at $2.11</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 3.52% at $116.17</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 3.50% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 3.43% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.21% at $70.81</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 3.05% at $1.30</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed up 3.01% at $0.71</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 33.80% at $2.68</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 19.50% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 6.64% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 6.57% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 6.57% at $12.10</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 6.36% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ITHUF

Cannabis Stock Movers For August 8, 2024

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 25.22% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 25.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 11.54% at $1.29</li>
<li><a href="https://www.benzinga.com/quote/ZLDAF">Zelira Therapeutics</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZLDAF#OTC">ZLDAF</a>) shares closed up 10.55% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 9.37% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed up 7.31% at $2.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 6.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 4.90% at $0.58</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 4.17% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.24% at $0.18</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 36.17% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 34.18% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 19.03% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 16.16% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 11.83% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 11.35% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 10.53% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 10.14% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 7.44% at $9.20</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 6.53% at $1.86</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 6.13% at $56.66</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 5.75% at $0.38</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.26% at $3.60</li>
<li><a href="https://www.benzinga.com/quote/OGI">OrganiGram Holdings</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed down 5.10% at $1.49</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 4.73% at $71.66</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 3.83% at $2.29</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 3.65% at $1.55</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 3.53% at $6.57</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed down 3.34% at $114.27</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 3.16% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 3.15% at $117.71</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

YCBD

ZLDAF

Marijuana Stock Movers For August 2, 2024

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) with a Hold and raises the price target from $70 to $75.

Price Target

Analyst Ratings

Stifel Maintains Hold on Scotts Miracle Gro, Raises Price Target to $75

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 71.11% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/HERTF">Heritage Cannabis Holding</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HERTF#OTC">HERTF</a>) shares closed up 28.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 23.50% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 8.98% at $0.68</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 8.83% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 8.60% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed up 7.20% at $11.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 6.65% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ACNNF">AusCann Group Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ACNNF#OTC">ACNNF</a>) shares closed up 6.62% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 5.43% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 5.26% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 5.26% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 4.52% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 4.46% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 3.58% at $0.10</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 34.72% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ZLDAF">Zelira Therapeutics</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZLDAF#OTC">ZLDAF</a>) shares closed down 27.59% at $0.40</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 24.87% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 20.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 13.95% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 10.53% at $6.77</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 9.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 7.27% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 7.14% at $1.30</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 6.48% at $0.56</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 5.96% at $2.35</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 5.63% at $2.18</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 5.40% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 4.92% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 4.72% at $0.55</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 4.30% at $75.22</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 4.00% at $8.88</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 3.96% at $1.11</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed down 3.85% at $118.22</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 3.85% at $0.06</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACNNF

HERTF

MGWFF

ZDPY

Cannabis Stock Movers For August 1, 2024

ABBV

AMZN

SPHD

CNBC Halftime Report Final Trades: Amazon.com, AbbVie, The Scotts Miracle-Gro Company, Invesco S&P 500 High Dividend Low Volatility ETF

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) with a Overweight and raises the price target from $75 to $85.

Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $85

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 44.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ACNNF">AusCann Group Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ACNNF#OTC">ACNNF</a>) shares closed up 36.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 25.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 15.38% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 12.08% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 11.90% at $78.60</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 11.04% at $9.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 9.92% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 9.36% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 6.98% at $6.15</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 6.16% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 5.45% at $1.72</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 5.44% at $0.58</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 4.74% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 4.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 4.34% at $0.40</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 3.98% at $0.10</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/EPWCF">Empower Clinics</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EPWCF#OTC">EPWCF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 33.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 15.32% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 10.97% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 10.79% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 10.00% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed down 4.65% at $2.28</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 3.45% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed down 3.27% at $0.82</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EMPOWER CLINICS INC by Empower Clinics Inc.

EPWCF

Cannabis Stock Gainers And Losers From July 31, 2024

U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Wednesday.
Shares of Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) surged 15% to $38.74 after the company reported better-than-expected second-quarter revenue results and issued str<a href="https://www.benzinga.com/news/earnings/24/07/40051630/match-group-stock-climbs-on-strong-q2-results-hinge-revenue-up-48">ong third-quarter revenue guidance</a>.
Match Group reported quarterly earnings of 48 cents per share, in-line with the analyst consensus estimate. Quarterly sales clocked in at $864 million which beat the analyst consensus estimate of $856.4 million and is a 4.15% increase from the same period last year.
Match Group surged 15% to $38.74 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) jumped 33.2% to $177.43 after the company reported better-than-expected Q3 GAAP EPS and sales.</li>
<li>Stardust Power Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) shares surged 23.9% to $14.65.</li>
<li>Modine Manufacturing Company&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) surged 20.2% to $118.85 after the company reported better-than-expected&nbsp;first-quarter&nbsp;financial results.</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) surged 19.6% to $21.01.</li>
<li>Fiverr International Ltd.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVRR#NYSE">FVRR</a>) jumped 18.5% to $25.94 after the company reported better-than-expected second-quarter financial results.</li>
<li>Parsons Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSN#NYSE">PSN</a>) gained 16.4% to $89.82 after the company reported better-than-expected second-quarter financial results and raised its FY24 revenue guidance above estimates.</li>
<li>Talen Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NYSE">TLN</a>) rose 13.6% to $125.98.</li>
<li>The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) jumped 12.7% to $79.17 following better-than-expected quarterly financial results.</li>
<li>Caesars Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) gained 12.6% to $41.56 following second-quarter earnings.</li>
<li>Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) jumped 11.1% to $187.41.</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) gained 11% to $115.04.</li>
<li>Arista Networks, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) rose 8.8% to $338.70 as the company reported better-than-expected second-quarter financial results and raised its third-quarter revenue guidance.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) gained 8.7% to $17.84 after the company reported better-than-expected quarterly financial results and issued FY24 guidance.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/40068197/jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would">Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: &#8216;I Would Pick Some Up Tomorrow&#8217;</a></li>
</ul>

Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>), the world's largest marketer of branded consumer lawn and garden as well as a leader in indoor and hydroponic growing products, announced on Wednesday its results for the third quarter ended June 29, 2024.
Cannabis-focused subsidiary Hawthorne Gardening Company's net sales for the quarter decreased 28%, to $67.7 million, compared to $93.4 million last year. The company said the drop was largely due to the previously announced discontinuation of its third-party distributed brands business.
"Hawthorne has generated its first profitable quarter since the third quarter of fiscal 2022, a reflection that the changes we have made are strengthening the business despite continued industry hardships," Chris Hagedorn, division president, said. "We are on track to break-even or better adjusted EBITDA in fiscal 2024 and are positioning Hawthorne for future growth."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/02/37012901/scotts-miracle-gros-cannabis-focused-subsidiary-reports-39-yoy-revenue-drop-in-q1">Scotts Miracle-Gro&#8217;s Cannabis-Focused Subsidiary Reports 39% YoY Revenue Drop In Q1</a>
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
<ul>
<li>Total company sales amounted to $1.2 billion, representing an increase of 7% compared to $1.1 billion a year ago.</li>
<li>U.S. Consumer net sales increased 11% to $1 billion from $0.9 billion in the same period last year.</li>
<li>GAAP and non-GAAP adjusted gross margin rates were 29.5% and 29.2%, respectively. These compare to 18.4% and 21.3%, respectively, in the prior year.</li>
<li>Selling, general and administrative expenses increased 15% to $147.9 million during the quarter compared to $128.5 million a year ago.</li>
<li>Other expenses were $6.9 million in the quarter.</li>
<li>Non-GAAP adjusted net income, which excludes impairment, restructuring and other non-recurring items, more than doubled to $133.8 million, or $2.31 per diluted share, from $66 million, or $1.17 per diluted share, for the same period last year.</li>
</ul>
"Consumer engagement with our brands has remained high through fiscal ‘24, and we expect to drive continued participation through the fall with well-timed media and promotional plans in conjunction with our retail partners," Matt Garth, chief financial and administrative officer, said.
<h3 class="wp-block-heading">Fiscal 2024 Outlook</h3>
The Scotts Miracle-Gro Company reaffirmed the non-GAAP fiscal 2024 guidance issued in June with the exception of Hawthorne net sales.
That segment is now expected to end the fiscal year 35 to 40% lower than the prior year with progress exiting lower margin distributed brands and a projected decline in its professional horticulture lighting business.
The segment still expects to break even or better non-GAAP adjusted EBITDA for the full year in line with previous guidance.
<h3 class="wp-block-heading">SMG Price Action</h3>
The Scotts Miracle-Gro Company's shares traded 5.51% higher at $74.11 per share at the time of writing on Wednesday morning.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/06/39251909/class-action-lawsuit-against-scotts-miracle-gro-investors-allege-misleading-information-and-arti">Class Action Lawsuit Against Scotts Miracle-Gro: Investors Allege &#8216;Misleading Information&#8217; And &#8216;Artificially Inflated Prices&#8217;</a> </li>
</ul>
To learn more about cannabis stocks, come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.

Earnings

Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 28% YoY Drop In Q3 Net Sales, Reaffirms 2024 Outlook

WIIM

Scotts Miracle-Gro shares are trading higher following better-than-expected Q3 financial results.

Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $1.93 by 19.69 percent. The company reported quarterly sales of $1.202 billion which beat the analyst consensus estimate of $1.198 billion by 0.35 percent. This is a 7.42 percent increase over sales of $1.119 billion the same period last year.

Earnings Beats

Scotts Miracle Gro Q3 2024 Adj. EPS $2.31 Beats $1.93 Estimate, Sales $1.202B Beat $1.198B Estimate

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GRNH">GreenGro Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRNH#OTC">GRNH</a>) shares closed up 2800.00% at $2.9e-05</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 81.82% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 67.06% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 22.95% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 17.50% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 16.28% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 15.85% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed up 8.29% at $2.05</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 7.23% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 6.92% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 6.82% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 5.39% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 5.19% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 5.16% at $2.24</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.76% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 4.71% at $58.06</li>
<li><a href="https://www.benzinga.com/quote/GENE">Genetic Technologies</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) shares closed up 4.46% at $0.85</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.35% at $70.61</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 3.35% at $1.83</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 17.25% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 9.91% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 8.86% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 5.77% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 4.64% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 4.47% at $0.34</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.53% at $0.58</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 3.12% at $6.21</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GRNH

Bullish Friday For Marijuana Stocks - GreenGro Technologies, Leafbuyer Techs Among Top Gainers

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 117.39% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 19.90% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 19.40% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 11.81% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 10.37% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 6.01% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 4.77% at $0.72</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 4.53% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed up 3.52% at $2.24</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 3.11% at $0.63</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GGBXF">Green Growth Brands</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GGBXF#OTC">GGBXF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 96.33% at $0.0009</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 26.87% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/HERTF">Heritage Cannabis Holding</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HERTF#OTC">HERTF</a>) shares closed down 24.62% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 23.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 17.73% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 16.67% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 14.99% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 10.73% at $7.32</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 9.62% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 7.89% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 6.50% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 6.30% at $2.38</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 6.15% at $0.61</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 6.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 5.44% at $1.64</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.43% at $4.09</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed down 5.42% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 5.38% at $5.76</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 5.06% at $10.41</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 5.06% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.76% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 4.42% at $2.37</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 4.26% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 3.13% at $66.64</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLGVF

GGBXF

Cannabis Stock Gainers And Losers From July 24, 2024

PPG Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ppg#NYSE">PPG</a>) reported a second-quarter 2024 profit of $528 million or $2.24 per share, up from $490 million or $2.06 per share in the year-ago quarter.
In the second quarter, excluding one-time items, adjusted earnings per share increased to $2.50 from $2.25 in the year-ago quarter, surpassing the Zacks Consensus Estimate of $2.48.
The company&#39;s revenues were $4,794 million in the quarter, down 1.6% year over year. The top line missed the Zacks Consensus Estimate of $4,913.5 million.
<div class="chart_embed">
<h3>PPG Industries, Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="PPG Industries, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/d7/1721387769.png" style="height:265px; width:591px" title="" /></h3>
PPG Industries, Inc. price-consensus-eps-surprise-chart | PPG Industries, Inc. Quote
</div>
<h3>Segment Review</h3>
Performance Coatings&#39; second-quarter revenues were $3,048 million. The segment&#39;s net sales were stable, as improved selling prices were offset by the sale of the non-North American portion of the traffic solutions business and adverse foreign currency translation. The figure was below our estimate of $3,101.8 million.
Industrial Coatings generated revenues of $1,746 million, a 4.6% year-over-year decrease. The fall is due to lower selling prices from certain index-based customer contracts and unfavorable foreign currency translation. The figure was below our estimate of $1,831.9 million.
<h3>Financials</h3>
The company had $1.2 billion in cash and short-term investments as of the end of the quarter. Net debt was $5.2 billion, down $0.4 billion from the prior-year quarter.
<h3>Outlook</h3>
The company&#39;s projected adjusted EPS for the third quarter is in the range of $2.10-$2.20. For the full year, the company expects adjusted EPS in the range of $8.15-$8.30. These projections consider various factors such as current global economic activity, uneven global industrial production, reduced global automotive production, stabilizing demand in Europe, sustained growth in Mexico and India and low single-digit growth in China.
<h3>Price Performance</h3>
Shares of PPG have lost 12.1% over the past year compared with 12.8% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/70/71889.jpg?v=1979758973" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Upcoming Releases</h3>
PPG currently carries a Zacks Rank #4 (Sell).
Some other firms in the basic materials space that are set to release earnings soon are The Scotts Miracle-Gro Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smg#NYSE">SMG</a>), Ero Copper Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ero#NYSE">ERO</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>).
Scotts Miracle-Gro is slated to report fiscal third-quarter results on Jul 31. The Zacks Consensus Estimate for third-quarter earnings is pegged at $1.94 per share. SMG beat the Zacks Consensus Estimate in three of the last four quarters, with the average earnings surprise being 1.44%. SMG carries a Zacks Rank #3 (Hold).
Ero Copper is slated to report second-quarter results on Aug 1, after market close. The Zacks Consensus Estimate for ERO&#39;s second-quarter earnings is pegged at 27 cents. ERO currently carries a Zacks Rank #1.
Innospec is slated to report second-quarter results on Aug 6, after market close. The consensus estimate for Innospec&#39;s second-quarter earnings is pegged at $1.37 per share. IOSP, carrying a Zacks Rank #3, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 8.22%. The company&#39;s shares have gained around 24.5% in the past year.
<a href="https://www.zacks.com/stock/news/2305079/ppg-industries-ppg-q2-earnings-top-estimates-sales-lag?cid=CS-BENZ-FT-analyst_blog|earnings_article-2305079">To read this article on Zacks.com click here.</a>

IOSP

PPG Industries Q2 Earnings Top Estimates, Sales Lag

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</h3>
<ul>
<li>Dividend Yield: 5.05%</li>
<li>Mizuho analyst John Roberts maintained a Neutral rating and increased the price target from $55 to $62 on April 26. This analyst has an accuracy rate of 77%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas upgraded the stock from Neutral to Overweight and boosted the price target from $55 to $61 on April 26. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On June 20, , Dow signed an agreement to acquire Circulus, a leading recycler of plastic waste into post-consumer resin.</li>
<li><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">Benzinga Pro's real-time newsfeed</a> alerted to latest DOW news</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="685" height="716" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png" alt="" class="wp-image-442560" style="width:312px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM.png 685w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052217/Screenshot-2024-07-18-at-2.52.06-PM-287x300.png 287w" sizes="(max-width: 685px) 100vw, 685px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul>
<li>Dividend Yield: 4.22%</li>
<li>Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $32 to $28 on July 11. This analyst has an accuracy rate of 71%.</li>
<li>JP Morgan analyst Jeffrey Zekauskasupgraded the stock from Underweight to Overweight and boosted the price target from $22 to $27 on June 7. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: Huntsman is scheduled to hold a conference call on Tuesday, Aug. 6, 2024, to discuss its second quarter financial results.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">trend in HUN's stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="693" height="745" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png" alt="" class="wp-image-442561" style="width:479px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM.png 693w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052250/Screenshot-2024-07-18-at-2.52.45-PM-279x300.png 279w" sizes="(max-width: 693px) 100vw, 693px" /></a></figure>
<h3 class="wp-block-heading">The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>)</h3>
<ul>
<li>Dividend Yield: 3.93%</li>
<li>JP Morgan analyst Jeffrey Zekauskasmaintained an Overweight rating and raised the price target from $70 to $85 on April 5. This analyst has an accuracy rate of 70%.</li>
<li>Raymond James analyst Joseph Altobello downgraded the stock from Strong Buy to Market Perform on March 25. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On June 6, ScottsMiracle-Gro said it now sees non-GAAP adjusted EBITDA of $530 million to $540 million versus earlier outlook of $575 million.</li>
<li>Benzinga Pro's earnings calendar was used to monitor <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">SMG's upcoming earnings</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="647" height="740" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png" alt="" class="wp-image-442562" style="width:414px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM.png 647w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/18052412/Screenshot-2024-07-18-at-2.54.05-PM-262x300.png 262w" sizes="(max-width: 647px) 100vw, 647px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39814553/jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there">Jim Cramer Says Don&#8217;t Sell Match Group: &#8216;You&#8217;ve Just Got A Very, Very Smart Investor In There</a>&#8216;</li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

Dividends

Pre-Market Outlook

Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields

Scotts Miracle-Gro Q3 2024 Earnings Preview

Scotts Miracle-Gro declares $0.66 dividend

Scotts Miracle-Gro Non-GAAP EPS of $2.31 beats by $0.39, revenue of $1.2B in-line

The Scotts Miracle-Gro Company 2024 Q3 - Results - Earnings Call Presentation

The Scotts Miracle-Gro Company (SMG) Q3 2024 Earnings Call Transcript

Truist Financial analyst Bill Chappell maintained a Hold rating on Scotts Miracle-Gro Company (SMG – Research Report) today. The company's shares c...

Truist Financial Sticks to Their Hold Rating for Scotts Miracle-Gro Company (SMG)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Make no mistake: it&rsquo;s still a time when you should be thinking about which <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> to sell, not which cannabis stocks to buy. Yes, based on the <a href="https://www.cannabisbusinesstimes.com/news/federal-marijuana-schedule-dea-doj-comments-when-hearings-proposed-rescheduling-cannabis-rul/">sheer volume of public comments</a> submitted to the Drug Enforcement Administration (<a href="https://investorplace.com/stock-quotes/dea-stock-quote/">DEA</a>) in support of a proposed rescheduling of marijuana, U.S. cannabis legalization progress seemingly keeps moving in the right direction.



It&rsquo;s also true that political developments may also bode well for legalization. With Vice President Kamala Harris, <a href="https://www.benzinga.com/markets/cannabis/24/07/39998398/kamala-harris-admits-i-inhaled-marijuana-and-now-pushes-for-legalization-what-this-means-for-202">far more pro-legalization</a> than President Biden, now the Democratic Party&rsquo;s candidate for the 2024 U.S. presidential election, it&rsquo;s possible that a few months from now, a Blue wave leads to renewed speculation about rapid reforms to America&rsquo;s pot laws.



Still, despite some promise on the horizon, for now, expect poor fundamentals to outweigh this promise in the price performance of the most widely-followed cannabis stocks. These cannabis stocks to sell include not just Canada-based marijuana companies, which are still struggling due to their inability to enter the U.S. market. U.S.-based, state-licensed operators face many issues as well.



Until reclassification becomes official, they must contend with <a href="https://www.wsj.com/business/cannabis-companies-profits-taxes-3f8bbee0">higher income taxes.</a> Irrespective of regulatory changes, they are poised to face further <a href="https://www.greenmarketreport.com/major-changes-to-cannabis-banking-unlikely-after-rescheduling/">banking challenges.</a>



<h2>Aurora Cannabis (ACB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/acb_auroracannabis1600-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company Aurora Cannabis (ACB, blurred marijuana leaf (focus on left part of letter R in center)"><div>Source: Ralf Liebhold / Shutterstock.com</div></div>Aurora Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/acb-stock-quote/">ACB</a>) is one of several major U.S.-listed Canada-based cannabis companies. Shares may be up in recent weeks due to the above-mentioned reclassification news, but over the span of several years, shareholder value has gone up in smoke.



Since 2019, ACB stock has experienced a more than 99% decline in price. During this time, the stock has gone from a split-adjusted $900 per share to around $6 per share today. A big reason for this was heavy cash burn, which led to multiple rounds of dilutive equity raises. Admittedly, Aurora Cannabis has been successful at mitigating its cash burn issue since 2023. On an EBITDA basis, <a href="https://seekingalpha.com/symbol/ACB/income-statement">the company is operating at near-breakeven levels.</a> However, don&rsquo;t assume this means further improvements to fiscal performance are just around the corner.



As InvestorPlace&rsquo;s Yiannis Zourmpanos recently argued, Aurora&rsquo;s adjusted gross margins have been slipping lately, falling from <a href="https://investorplace.com/2024/07/timebomb-ticking-3-stocks-to-offload-before-the-crash/">25% to 16%</a> over the past few fiscal quarters. If the company once again reports margin issues in its upcoming quarterly earnings release on Aug. 9, it could spark a new round of concern about Aurora Cannabis&rsquo; future prospects. Shares could cough back their reclassification-related gains &mdash; and then some.



<h2>Canopy Growth (CGC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/cgc-1600-1-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company canopy growth cannabis, blurred marijuana in the background. CGC stock."><div>Source: Ralf Liebhold / Shutterstock</div></div>Canopy Growth (NYSE:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) is another of the Canada-based cannabis stocks to sell. Unable to enter the U.S. market until marijuana becomes fully legal under federal law, Canopy has been in a serious slump for several years. Revenues have steadily declined while operating losses have stayed high.



This has led to continued heavy dilution with CGC stock. At first, this came in the form of capital infusions from a deep-pocketed strategic investor, beverage company Constellation Brands (NYSE:<a href="https://investorplace.com/stock-quotes/stz-stock-quote/">STZ</a>). So far this year, however, the U.S.-based beer and wine giant has <a href="https://www.fooddive.com/news/constellation-canopy-growth-shares-distancing-board-non-voting-biden-fda-regulation-cannabis/713734/">all but thrown in the towel</a> on what&rsquo;s turned out to be a $4 billion bad bet. As a result, the company is now tapping into other funding sources.



Back in June, Canopy Growth launched a <a href="https://seekingalpha.com/news/4113607-canopy-growth-stock-slips-on-250m-equity-program">$250 million</a> at-the-market program to sell newly-issued CGC shares on the open market. That said, no matter where the company finds fresh capital to sustain operations, what matters for investors is that challenging times are likely to continue. Per sell-side forecasts, the company is expected to report <a href="https://seekingalpha.com/symbol/CGC/earnings">losses of $1.03 per share</a> this fiscal year. That&rsquo;s a pretty penny, as CGC currently trades for only $6.77 per share.



<h2>Curaleaf Holdings (CURLF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/02/marijuana-cannabis-stocks-1600-300x169.png" alt="marijuana stocks Hand gently holding rich soil for his marijuana plants. Cannabis Stocks"><div>Source: Jetacom Autofocus / Shutterstock.com</div></div>After looking at several Canada-based cannabis purveyors, let&rsquo;s take a look at Curaleaf Holdings (OTCMKTS:<a href="https://investorplace.com/stock-quotes/curlf-stock-quote/">CURLF</a>), one of the largest multi-state operators (MSOs), or U.S. state-licensed, cannabis companies. Headquartered in New York, Curaleaf has operations all across the U.S., including populous jurisdictions like Florida, Illinois and New Jersey.



As I argued last month, numerous factors <a href="https://investorplace.com/2024/07/7-cannabis-stocks-to-sell-in-july-before-they-crash-burn/">could</a> cause a pullback for CURLF stock. High debt, for one. Valuation is another. CURLF&rsquo;s stock price has been largely unchanged since I last wrote about it, and the company continues to trade at a premium to peers on an enterprise value-to-EBITDA (EV/EBITDA) basis. Yes, these factors may not matter much a few months from now if regulatory and political changes lead to another cannabis stock boom.



However, between now and then, these issues could impact Curaleaf&rsquo;s stock price performance in the near term. The company is scheduled to report earnings on Aug. 7. Investors looking to exit positions could use any negative aspect from the earnings release, whether the results themselves or updates to guidance, as justification to sell. As I put it before, CURLF could be a buy at lower prices, but stay away for now.



<h2>Scotts Miracle-Gro (SMG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/smg1600-300x169.jpg" alt="Scotts Miracle-Gro logo displayed on a web browser and magnified by a magnifying glass"><div>Source: Casimiro PT / Shutterstock.com</div></div>Scotts Miracle-Gro (NYSE:<a href="https://investorplace.com/stock-quotes/smg-stock-quote/">SMG</a>) is primarily a lawn and garden care products company, but over the years, through its Hawthorne Gardening subsidiary, SMG has become a major player in the cannabis cultivation space. However, in 2022 and 2023, this <a href="https://www.forbes.com/sites/willyakowicz/2024/01/12/scotts-miracle-gro-cannabis-1-7-billion-dollars-hawthorne-james-hagedorn-chris-hagedorn/">$1.7 billion wager has soured.</a>



Hawthorne&rsquo;s weak performance, coupled with other factors, led to overall declines in revenue and profitability. In turn, that drove a sharp drop in the SMG stock price since 2021. Sure, in more recent quarters, fiscal performance has bounced back. This has resulted in a rebound for SMG shares of nearly 18%. Scott Miracle-Gro&rsquo;s <a href="https://seekingalpha.com/news/4130899-scotts-miracle-gro-non-gaap-eps-of-2_31-beats-0_39-revenue-of-1_2b-in-line">latest earnings beat</a> resulted in shares hitting a new 52-week high on July 31.



However, following this sentiment shift, SMG now trades for <a href="https://stockanalysis.com/stocks/smg/statistics/">around</a> 21.7 times forward earnings. This represents a big valuation premium to other agricultural input companies. For now, bullishness about legalization could sustain SMG&rsquo;s current share price. If hope and hype fade, though, it may cause the stock to start moving in the wrong direction once again. Downside risk may be more modest here than, with more speculative pot plays. Nevertheless, you may want to stay away.



<h2>SNDL (SNDL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/sndl-1600-300x169.png" alt="The Sundial Growers logo is on a phone screen with a light blue background in front of the sundial logo on a white background. SNDL stock"><div>Source: Shutterstock</div></div>SNDL (NASDAQ:<a href="https://investorplace.com/stock-quotes/sndl-stock-quote/">SNDL</a>), which you may remember from its prior corporate name, Sundial Growers, started off as a Canada-based cannabis pure play. In more recent years, however, the company has diversified. Alongside cannabis cultivation and retail operations, SNDL has made substantial debt and equity investments in other cannabis companies.



For the past years, SNDL has also been a liquor retailing company. Via its <a href="https://www.prnewswire.com/news-releases/sundial-growers-completes-acquisition-of-alcanna-301514512.html">2022 acquisition of Alcanna,</a> the company owns Canadian liquor store chains Ace Liquor Discounter and Liquor Depot as well as beer, wine and spirit retailer Wine and Beyond. Nevertheless, it&rsquo;s not as if this diversification effort has led to a recovery for shares, which have fallen by more than 97% since 2019.



SNDL&rsquo;s just-released quarterly fiscal results were mixed at best. Although <a href="https://www.prnewswire.com/news-releases/sndl-reports-second-quarter-2024-financial-and-operational-results-302213153.html">negative cash flow narrowed,</a> net revenue fell slightly. There is also the expectation that the former Sundial will report positive earnings this year. Shares trade for around 20 times this forecast. However, if the company continues reporting net losses like it did last quarter, 2024 estimates may soon need to be walked back. The resultant disappointment could place a new round of pressure on shares. With this, consider SNDL one of the cannabis stocks to sell.



<h2>Tilray Brands (TLRY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/tlry_tilray1600-2-300x169.png" alt="Close view of Tilray (TLRY) logo on a smart phone. Tilray specializes in cannabis research, cultivation, processing and distribution. TLRY stock"><div>Source: Lori Butcher / Shutterstock.com</div></div>With Tilray Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlry-stock-quote/">TLRY</a>), it&rsquo;s even more abundantly clear that poor fundamentals make it a sell, no matter how much the regulatory environment for cannabis in the U.S. could get just a few months from now. As Seeking Alpha commentator Stone Fox Capital recently pointed out, <a href="https://seekingalpha.com/article/4707916-tilray-never-great-under-surface">there are several red flags with TLRY.</a>



First, this Canada-based cannabis purveyor is lacking when it comes to organic growth. In recent quarters, revenues have only increased due to the impact of Tilray&rsquo;s acquisition of several craft beer brands from Anheuser-Busch InBev (NYSE:<a href="https://investorplace.com/stock-quotes/bud-stock-quote/">BUD</a>). Second, despite this inconvenient detail, plus the mixed performance of Tilray&rsquo;s cannabis segment, TLRY stock still trades at a premium valuation compared to peers. Adding to Stone Fox Capital&rsquo;s point, one can argue that the craft beer acquisition now makes Tilray more of a brewer than it does a cannabis company.



Besides really calling TLRY&rsquo;s valuation into question, this also suggests that, even if U.S. cannabis legalization arrives sooner rather than later, it will likely be less of a needle-mover for Tilray than for most of the other cannabis companies listed above and below. Considering its less-stellar risk/reward proposition, sell and/or avoid TLRY.



<h2>Verano Holdings (VRNOF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/cannabis_1600_1793299462-300x169.png" alt="Young green medicinal marijuana plant in a pot after a rain fall shallow depth of field with focus on leaf; cannabis stocks"><div>Source: gvictoria / Shutterstock.com</div></div>Based in Chicago, Illinois, Verano Holdings (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vrnof-stock-quote/">VRNOF</a>) is another large MSO. The company, which is <a href="https://s27.q4cdn.com/702412356/files/doc_presentations/2024/Jul/29/verano-2024-investor-deck-07-29-24.pdf">America&rsquo;s fourth-largest MSO,</a> operates in a total of 13 U.S. states. Vertically integrated, with cultivation, wholesale and retailing segments, Verano may (on paper) appear well-positioned to thrive if cannabis becomes fully legal across the United States.



Still, compared to similar names, Verano may be less likely to &ldquo;crush it&rdquo; if or when big regulatory changes occur. After all, as seen in recent quarterly results, gross profit growth has stagnated and operating income has declined compared to last year. While not certain, it&rsquo;s possible VRNOF stock may be at risk of greater share price decline, given it doesn&rsquo;t have something like high organic growth to fall back on if regulatory changes fail to take shape starting later this year.



Trading at a trailing EV/EBITDA ratio of only 6, investors have clearly accounted for Verano&rsquo;s weaknesses already. Then again, if VRNOF is selling at a discounted multiple during a time of stronger sentiment for cannabis plays, a sentiment shift could just turn it into a value trap. For these reasons, consider VRNOF one of the cannabis stocks to sell.



On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/7-struggling-cannabis-stocks-to-sell-by-2025/">7 Struggling Cannabis Stocks to Sell by 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Struggling Cannabis Stocks to Sell by 2025

Goldman screens for post-selloff stocks with healthy fundamentals at a discount

Poll shows support for marijuana legalization, cannabis banking in swing states

Scotts Miracle-Gro: A Turnaround Is Very Probable

AAWH

AVTR

AYRWF

CART

CBRE

CNBS

COLB

ENOV

EWBC

GNRC

JUSHF

MKSI

NCLH

RVTY

SIRI

TOST

VRNOF

WOLF

ZION

Press Releases

Investors in The Scotts Miracle-Gro Company Should Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - SMG

SMG Investors Have Opportunity to Join The Scotts Miracle-Gro Company Fraud Investigation with the Schall Law Firm

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Scotts Miracle-Gro Company (SMG)

Legal

DEADLINE ALERT for MRNS, and SMG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Scotts Lawsuit – SMG

SCOTTS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Scotts Miracle-Gro Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in The Scotts Miracle-Gro Company to Contact Law Firm

ScottsMiracle-Gro's Fort Madison Plant Celebrates 365 Day Safety Record

Kaskela Law LLC Announces Shareholder Investigation of The Scotts Miracle-Gro Company (NYSE: SMG) and Encourages Long-Term SMG Shareholders to Contact the Firm

MRNS

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Scotts Miracle Gro

Scotts Miracle Gro (SMG) Forecast

Scotts Miracle Gro (NYSE:SMG) Stock, Quote.Headers.trade-ideas